Osteoporosis in men

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Osteoporosis in men has become much more prominent as its prevalence and impact have become apparent. Fractures in men are common and of great importance to both individuals and society. Although in many ways the character of osteoporosis in men is similar to that in women, there are important differences as well. For instance, the rate of morbidity and mortality after a hip fracture s greater in men, probably because of more concomitant illness. The causation of osteoporosis in men and the approach to diagnosis are also somewhat different. Of particular importance is the impact of gonadal insufficiency and the relative roles of androgens and estrogen in male skeletal health. Apparently both sex steroids are essential, but the mechanisms by which each affects bone metabolism are unclear. Approaches to the prevention and therapy of osteoporosis in men have been developed. Evidence supports the effectiveness of vitamin D and calcium supplementation, and bisphosphonates are effective in preventing bone loss and fractures in several situations. New therapies (parathyroid hormone, selective estrogens and androgens) are on the horizon. (C) 2000 Lippincott Williams and Wilkins, Inc.

Original languageEnglish (US)
Pages (from-to)303-309
Number of pages7
JournalCurrent Opinion in Endocrinology and Diabetes
Volume7
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Osteoporosis
Androgens
Estrogens
Bone Fractures
Hip Fractures
Diphosphonates
Parathyroid Hormone
Vitamin D
Causality
Steroids
Calcium
Morbidity
Bone and Bones
Mortality
Health
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Osteoporosis in men. / Orwoll, Eric.

In: Current Opinion in Endocrinology and Diabetes, Vol. 7, No. 6, 2000, p. 303-309.

Research output: Contribution to journalArticle

@article{e82ca4c8d2de4aea89f319591860827c,
title = "Osteoporosis in men",
abstract = "Osteoporosis in men has become much more prominent as its prevalence and impact have become apparent. Fractures in men are common and of great importance to both individuals and society. Although in many ways the character of osteoporosis in men is similar to that in women, there are important differences as well. For instance, the rate of morbidity and mortality after a hip fracture s greater in men, probably because of more concomitant illness. The causation of osteoporosis in men and the approach to diagnosis are also somewhat different. Of particular importance is the impact of gonadal insufficiency and the relative roles of androgens and estrogen in male skeletal health. Apparently both sex steroids are essential, but the mechanisms by which each affects bone metabolism are unclear. Approaches to the prevention and therapy of osteoporosis in men have been developed. Evidence supports the effectiveness of vitamin D and calcium supplementation, and bisphosphonates are effective in preventing bone loss and fractures in several situations. New therapies (parathyroid hormone, selective estrogens and androgens) are on the horizon. (C) 2000 Lippincott Williams and Wilkins, Inc.",
author = "Eric Orwoll",
year = "2000",
doi = "10.1097/00060793-200012000-00003",
language = "English (US)",
volume = "7",
pages = "303--309",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Osteoporosis in men

AU - Orwoll, Eric

PY - 2000

Y1 - 2000

N2 - Osteoporosis in men has become much more prominent as its prevalence and impact have become apparent. Fractures in men are common and of great importance to both individuals and society. Although in many ways the character of osteoporosis in men is similar to that in women, there are important differences as well. For instance, the rate of morbidity and mortality after a hip fracture s greater in men, probably because of more concomitant illness. The causation of osteoporosis in men and the approach to diagnosis are also somewhat different. Of particular importance is the impact of gonadal insufficiency and the relative roles of androgens and estrogen in male skeletal health. Apparently both sex steroids are essential, but the mechanisms by which each affects bone metabolism are unclear. Approaches to the prevention and therapy of osteoporosis in men have been developed. Evidence supports the effectiveness of vitamin D and calcium supplementation, and bisphosphonates are effective in preventing bone loss and fractures in several situations. New therapies (parathyroid hormone, selective estrogens and androgens) are on the horizon. (C) 2000 Lippincott Williams and Wilkins, Inc.

AB - Osteoporosis in men has become much more prominent as its prevalence and impact have become apparent. Fractures in men are common and of great importance to both individuals and society. Although in many ways the character of osteoporosis in men is similar to that in women, there are important differences as well. For instance, the rate of morbidity and mortality after a hip fracture s greater in men, probably because of more concomitant illness. The causation of osteoporosis in men and the approach to diagnosis are also somewhat different. Of particular importance is the impact of gonadal insufficiency and the relative roles of androgens and estrogen in male skeletal health. Apparently both sex steroids are essential, but the mechanisms by which each affects bone metabolism are unclear. Approaches to the prevention and therapy of osteoporosis in men have been developed. Evidence supports the effectiveness of vitamin D and calcium supplementation, and bisphosphonates are effective in preventing bone loss and fractures in several situations. New therapies (parathyroid hormone, selective estrogens and androgens) are on the horizon. (C) 2000 Lippincott Williams and Wilkins, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033662704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033662704&partnerID=8YFLogxK

U2 - 10.1097/00060793-200012000-00003

DO - 10.1097/00060793-200012000-00003

M3 - Article

AN - SCOPUS:0033662704

VL - 7

SP - 303

EP - 309

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 6

ER -